Moreover, the fact that the ALS patients are not associated with a single haplotype may explain why ATXN2 has not emerged as a significant contributor to ALS from genome wide association (GWA) studies [50]–[53]. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.